167 related articles for article (PubMed ID: 33636046)
1. A systematic review of the barriers to implementing human papillomavirus vaccination programs in low- and middle-income countries in the Asia-Pacific.
Ver AT; Notarte KI; Velasco JV; Buac KM; Nazareno J; Lozañes JA; Antonio D; Bacorro W
Asia Pac J Clin Oncol; 2021 Dec; 17(6):530-545. PubMed ID: 33636046
[TBL] [Abstract][Full Text] [Related]
2. National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.
Tsu VD; LaMontagne DS; Atuhebwe P; Bloem PN; Ndiaye C
Prev Med; 2021 Mar; 144():106335. PubMed ID: 33678232
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review.
Zhu K; Tian Y; Dong X; Akinwunmi BO; Zhang CJP; Huang J; Ming WK
Arch Gynecol Obstet; 2022 Jul; 306(1):173-187. PubMed ID: 35380278
[TBL] [Abstract][Full Text] [Related]
4. Communication around HPV vaccination for adolescents in low- and middle-income countries: a systematic scoping overview of systematic reviews.
Foss HS; Oldervoll A; Fretheim A; Glenton C; Lewin S
Syst Rev; 2019 Aug; 8(1):190. PubMed ID: 31370886
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Human Papillomavirus Vaccination in Low- and Middle-Income Countries-Time for Implementation?
Gallant D; Tummers P; Weyers S; Merckx M
J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):586-590. PubMed ID: 34144176
[TBL] [Abstract][Full Text] [Related]
7. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
Okeah BO; Ridyard CH
Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
[TBL] [Abstract][Full Text] [Related]
8. Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.
Obel J; McKenzie J; Buenconsejo-Lum LE; Durand AM; Ekeroma A; Souares Y; Hoy D; Baravilala W; Garland SM; Kjaer SK; Roth A
Asian Pac J Cancer Prev; 2015; 16(8):3435-42. PubMed ID: 25921158
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review.
Kutz JM; Rausche P; Gheit T; Puradiredja DI; Fusco D
BMC Public Health; 2023 May; 23(1):974. PubMed ID: 37237329
[TBL] [Abstract][Full Text] [Related]
10. What works for human papillomavirus vaccine introduction in low and middle-income countries?
Howard N; Gallagher KE; Mounier-Jack S; Burchett HED; Kabakama S; LaMontagne DS; Watson-Jones D
Papillomavirus Res; 2017 Dec; 4():22-25. PubMed ID: 29179865
[TBL] [Abstract][Full Text] [Related]
11. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
Guillaume D; Waheed DE; Schleiff M; Muralidharan KK; Vorsters A; Limaye RJ
PLoS One; 2024; 19(1):e0291990. PubMed ID: 38227567
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
13. Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments.
Lack A; Hiligsmann M; Bloem P; Tünneßen M; Hutubessy R
Vaccine; 2020 Oct; 38(46):7226-7238. PubMed ID: 33023774
[TBL] [Abstract][Full Text] [Related]
14. Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review.
Ekwunife OI; Grote AG; Mosch C; O'Mahony JF; Lhachimi SK
Syst Rev; 2015 May; 4():68. PubMed ID: 25963745
[TBL] [Abstract][Full Text] [Related]
15. Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.
Islam JY; Gurbani A; Ramos S; Morgan K; Kim CJ; Richter KL; de Sanjose S; Smith JS; Vielot NA
Sex Transm Dis; 2021 Aug; 48(8):557-564. PubMed ID: 34014055
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective.
Ebrahimi N; Yousefi Z; Khosravi G; Malayeri FE; Golabi M; Askarzadeh M; Shams MH; Ghezelbash B; Eskandari N
Front Immunol; 2023; 14():1150238. PubMed ID: 37261366
[TBL] [Abstract][Full Text] [Related]
17. Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness.
Soe NN; Ong JJ; Ma X; Fairley CK; Latt PM; Jing J; Cheng F; Zhang L
Hum Vaccin Immunother; 2018; 14(12):3010-3018. PubMed ID: 30024823
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects.
Wigle J; Coast E; Watson-Jones D
Vaccine; 2013 Aug; 31(37):3811-7. PubMed ID: 23777956
[TBL] [Abstract][Full Text] [Related]
19. Identifying Perceived Barriers to Human Papillomavirus Vaccination as a Preventative Strategy for Cervical Cancer in Nigeria.
Nguyen NY; Okeke E; Anglemyer A; Brock T
Ann Glob Health; 2020 Sep; 86(1):118. PubMed ID: 32983914
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
Lim ASE; Lim RBT
Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
